FDA GRANTS SEASTAR MEDICAL BREAKTHROUGH DEVICE DESIGNATION FOR ITS SCD THERAPY FOR THE TREATMENT OF HYPERINFLAMMATION IN ADULT PATIENTS WITH SEPSIS OR A SEPTIC CONDITION

Reuters · 3d ago

Please log in to view news